Advertisement

Topics

Seattle Genetics Inc. Company Profile

11:44 EDT 19th April 2018 | BioPortfolio

Seattle Genetics is an innovative biotechnology company dedicated to improving the lives of people with cancer through novel antibody-based therapies. The company’s industry-leading antibody-drug conjugate (ADC) technology harnesses the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. Seattle Genetics commercializes ADCETRIS® (brentuximab vedotin) for the treatment of several types of CD30-expressing lymphomas. The company is also advancing a robust pipeline of novel therapies for solid tumors and blood-related cancers designed to address significant unmet medical needs and improve treatment outcomes for patients. More information can be found at www.seattlegenetics.com and follow @SeattleGenetics on Twitter.


News Articles [588 Associated News Articles listed on BioPortfolio]

PharmaMar lizensiert vollsynthetisch aus Meeressubstanzen gewonnene Payloads für Wirkstoff-Konjugate an Seattle Genetics

Madrid (ots/PRNewswire) - PharmaMar (MCE: PHM) hat heute die Unterzeichnung einer exklusiven Lizenzvereinbarung mit Seattle Genetics Inc. (SGEN: NASDAQ GS) bekanntgegeben, nach der Seattle Genetics...

Seattle Genetics to Acquire Cascadian Therapeutics for $614 Million, Adding Late-Stage Breast Cancer Program

att BOTHELL, Wash. & SEATTLE–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) and Cascadian Therapeutics, Inc. (Nasdaq:CASC) today announced the signing of a definitive merger agr...

Seattle Genetics Acquires Cascadian Therapeutics, Continuing a Strong ...

On January 31, two Seattle biotech companies, Seattle Genetics and Cascadian Therapeutics, announced a merger agreement under which Seattle Genetics will acquire Cascadian Therapeutics for $614 millio...

Seattle Genetics To Acquire Cascadian Therapeutics

NewsThe acquisition will enhance Seattle Genetics’ portfolio of solid tumor programs with potential rapid registration pathways and provides global rights to a pivotal Phase 2 program in development...

Seattle Genetics acquires Cascadian Therapeutics

Seattle Genetics Inc. agreed to pay $614mm ($10 per share in cash, a 107% premium) to acquire fellow Seattle-based cancer biotech Cascadian Therapeutics Inc.

Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics

Dobmeier will leave Seattle Genetics effective Jan. 1.

FDA accepts sBLA of Seattle Genetics’ ADCETRIS for Hodgkin lymphoma

The US Food and Drug Administration (FDA) has accepted filing of a supplemental biologics licence application (sBLA) by Seattle Genetics...Read More... The post FDA accepts sBLA of Seattle Genetics’...

Seattle Genetics, Inc. (SGEN) COO Eric Dobmeier Sells 9,600 Shares of Stock

Seattle Genetics, Inc. COO Eric Dobmeier sold 9,600 shares of Seattle Genetics stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $57.80, for...

PubMed Articles [553 Associated PubMed Articles listed on BioPortfolio]

Medical genetics and genomic medicine in the United States. Part 2: Reproductive genetics, newborn screening, genetic counseling, training, and registries.

Review of genetics in the United States with emphasis on the prenatal, metabolic, genetic counseling, and training aspects of the field.

Genetics and Psychiatry: Myth or Reality?

Greek mythology and philosophical speculations were the first human productions on madness and psychiatry. Likewise, the origins of genetics sink their roots in a very remote and difficult time. This ...

Recognition of clinical genetics in Europe.

From Mendel to Medical Genetics.

Correction to: Valgaeren, Koppen and Van Camp, A New Perspective on the Genetics of Keratoconus: Why Have We Not Been More Successful?

Clinical Trials [345 Associated Clinical Trials listed on BioPortfolio]

Impact of Non-Commercialism Policy in Seattle Schools

This pilot study on the impact of a non-commercialism policy in Seattle schools will assess and evaluate obesity-related health outcomes of a real-life policy decision, recently voted on a...

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Impact of Non-Commercialism Policy in Seattle Schools

This is a 3-year pilot study funded by National Institute of Health will assess and evaluate obesity-related health outcomes of a real-life policy decision, recently voted on and adopted b...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Reproducibility of Malaria Challenge in Healthy Volunteers

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the wel...

Companies [248 Associated Companies listed on BioPortfolio]

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

Seattle Genetics

Seattle Genetics, Inc. is a biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Our strategy is focused on advancing our portfolio...

Population Genetics

Harnessing The Power of Populations™ Population Genetics’ approach takes the process of genetic analysis one step further. It enables the elaboration and testing of distinct hypotheses...

More Information about "Seattle Genetics Inc." on BioPortfolio

We have published hundreds of Seattle Genetics Inc. news stories on BioPortfolio along with dozens of Seattle Genetics Inc. Clinical Trials and PubMed Articles about Seattle Genetics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Seattle Genetics Inc. Companies in our database. You can also find out about relevant Seattle Genetics Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...


Corporate Database Quicklinks



Searches Linking to this Company Record